Skip to main content
Clinical Trials/NCT07657364
NCT07657364RecruitingNot Applicable

Prosthetic Complications in Full-arch Screw-retained Implant Restorations Using Monolithic Zirconia Versus Titanium Frameworks: A Randomized Clinical Trial

Cairo University1 site in 1 country12 target enrollmentStarted: April 12, 2026Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
12
Locations
1

Study Overview

Brief Summary

The goal of this clinical trial is to to compare the prosthetic complication rate and Oral Health-Related Quality of Life (OHRQoL) between screw-retained monolithic zirconia frameworks and CNC-milled titanium frameworks with zirconia superstructures in completely edentulous patients restored with full-arch implant-supported prostheses over a follow-up period of 12 months.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Masking Description

Single-blind (Statistician)

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Aged 18 years or older.
  • Able to understand the study procedures and provide written informed consent.
  • In good general health, classified as American Society of Anesthesiologists (ASA) Physical Status Class I or II.
  • Completely edentulous in the arch to be treated (maxilla and/or mandible).
  • A candidate for a full-arch, screw-retained implant-supported prosthesis, requiring 4 to 6 implants in the treatment arch.
  • Sufficient bone volume at planned implant sites to place implants of at least 3.5mm in diameter and 8mm in length.
  • Adequate crown height space (15-22 mm) for a fixed prosthesis.
  • A zone of keratinized mucosa at the crest of the ridge measuring at least 2 mm in width.
  • Opposing arch is fixed full-arch implant-supported prosthesis.
  • Demonstrates acceptable oral hygiene and the motivation to maintain it.

Exclusion Criteria

  • Medical contraindications:
  • Uncontrolled diabetes (HbA1c > 7.0%).
  • History of radiotherapy in the head and neck region.
  • History of intravenous bisphosphonate therapy.
  • Immunosuppressed or immunocompromised status.
  • Any other uncontrolled systemic disease that constitutes a contraindication for oral surgery.
  • Behavioral Factors:
  • Heavy smoking, defined as consumption of more than 10 cigarettes per day.
  • Presence of parafunctional habits (e.g., bruxism, clenching) as diagnosed by clinical examination.
  • Local Oral Factors:
  • Active, untreated periodontal disease in any remaining dentition.
  • Presence of acute oral infection or pathology at the intended surgical site.
  • Crown height space less than 15 mm or more than 22 mm.
  • Insufficient keratinized mucosa (< 2 mm width) that cannot be corrected with a simple surgical procedure prior to implant placement.
  • Pregnancy or lactation.
  • Participation in another interventional clinical trial.
  • Perceived inability to comply with the study protocol and follow-up schedule.

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ahmad Diab Ahmad ElSayed

PhD researcher

Cairo University

Study Sites (1)

Loading locations...

Similar Trials